Medical and Pharmaceutical NRx Pharmaceuticals submits NDA for intravenous ketamine drug This therapeutic is specifically designed for suicidal depression Rowan DunneMarch 19, 2025
Psychedelics Edmonton’s new psychedelic therapy clinic helps residents soothe the winter blues It offers ketamine, psilocybin, and MDMA therapy sessions Rowan DunneJanuary 27, 2025
Medical and Pharmaceutical MIRA Pharma up 27% on ketamine analogue’s preclinical results for chemotherapy pain This pharmaceutical company is also developing a synthetic cannabinoid drug to treat anxiety and cognitive decline Rowan DunneOctober 30, 2024
Psychedelics Denver prepares to host psychedelic therapy expo in November It will attract over 1,000 attendees, the organizers claim Rowan DunneOctober 10, 2024
Psychedelics Kingston psychedelics complex celebrates grand opening The Centre for Psychedelics Health and Research was made possible with a donation from the Ontario Brain Institute Rowan DunneAugust 12, 2024
Psychedelics ATMA CENA opens Alberta psychedelic therapy clinics, Ontario locations to follow The treatment provider is a joint venture between ATMA Journey Centers and Cena Life Rowan DunneMarch 14, 2024
Psychedelics Believing you took ketamine during surgery has antidepressant effects: Stanford Medicine study All participants in the placebo group reported a 50 per cent drop in depression symptoms after surgery Rowan DunneOctober 20, 2023
Psychedelics Majority of Americans support regulating psychedelics: UC Berkeley survey The survey results follow the city of Berkeley decriminalizing psychedelic plants and fungi on Tuesday Rowan DunneJuly 13, 2023
Psychedelics Stella acquires Field Trip’s U.S. assets to enhance its psychedelic therapy offerings Stella closed a US$7 million funding round led by Sterling Partners last month Rowan DunneJune 28, 2023
Psychedelics FDA publishes first draft guidance document for psychedelics research It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics Rowan DunneJune 23, 2023